Relation of thrombomodulin, TFPI and plasma antioxidants in healthy individuals and patients with coronary heart disease.
OBJECTIVE
The role of antioxidants in preventing endothelial dysfunction has been discussed for many years and still is a controversial issue. This study is to determine the relation between markers of endothelial damage and plasma antioxidants in healthy individuals and patients with coronary heart disease (CHD).


RESULTS
Plasma concentration and activity of antioxidant b-carotene (beta-CAR), superoxide dismutase (SOD), vitamin C (VC) and vitamin E (VE) were measured in patients with coronary heart disease and healthy volunteers. Markers of endothelial damage, thrombomodulin and tissue factor pathway inhibitor (TFPI) were also measured. Levels of thrombomodulin in CHD patients and healthy individuals were 29.8 +/- 24.2 ng/mL and 21.7 +/- 10.8 ng/mL respectively. Levels of TFPI in CHD patients and healthy individuals were 114.1 +/- 19.4 ng/mL and 93.5 +/- 14.1 ng/mL, respectively. Both thrombomodulin and TFPI levels were significantly higher in CHD patients than healthy volunteers (P < 0.05 and P < 0.01, respectively). Levels of VC, VE, SOD and beta-CAR showed no significant differences between the two groups. In CHD patients, plasma thrombomodulin levels correlated negatively with plasma VC, VE and beta-CAR. TFPI levels correlated negatively with plasma VC,VE, beta-CAR and SOD. No significant relations could be found in healthy individuals between plasma thrombomodulin,TFPI and plasma antioxidants levels.


CONCLUSIONS
In CHD patients, serum antioxidant levels correlated significantly and negatively with endothelial damage.
Huang
Jinyu
J
Department of Cardiology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, China. dr-huangjinyu@hotmail.com
Fu
Guosheng
G
Yao
Qiang
Q
Cheng
Gang
G
D000368:Aged; D000975:Antioxidants / Q000378:metabolism*; D015415:Biomarkers / Q000097:blood; D003327:Coronary Disease / Q000097:blood*; D004730:Endothelium, Vascular / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012016:Reference Values; D012720:Severity of Illness Index; D018180:Thrombomodulin / Q000097:blood*
D000975:Antioxidants; D015415:Biomarkers; D008074:Lipoproteins; D018180:Thrombomodulin; C051928:lipoprotein-associated coagulation inhibitor